Listing #3539599 oncnursingnews.com
275
The FDA granted a priority review for a Biologics License Application (BLA) to
bastilimab for the treatment of recurrent or metastatic cervical cancer. Cancer ...
Category
Website Performance
| observedFirstPaintTs | 1015414813474 |
| firstMeaningfulPaint | 2.27 Sec |
| observedLoad | 2.03 Sec |
| observedDomContentLoaded | 0.28 Sec |
| totalBlockingTime | 0.63 Sec |
| observedTraceEnd | 7.98 Sec |
| observedSpeedIndexTs | 1015416840868 |
| maxPotentialFID | 0.27 Sec |
| observedCumulativeLayoutShiftMainFrame | 0 Sec |
| cumulativeLayoutShiftMainFrame | 0 Sec |
| observedFirstContentfulPaintTs | 1015414813474 |
| observedLargestContentfulPaint | 1.36 Sec |
| observedFirstContentfulPaintAllFrames | 0.3 Sec |
| observedFirstMeaningfulPaintTs | 1015415866875 |
| observedFirstContentfulPaint | 0.3 Sec |
| observedSpeedIndex | 2.33 Sec |
| observedLargestContentfulPaintAllFrames | 1.36 Sec |
| observedNavigationStartTs | 1015414511065 |
| observedTimeOrigin | 0 Sec |
| observedTotalCumulativeLayoutShift | 0 Sec |
| interactive | 6.94 Sec |
| observedDomContentLoadedTs | 1015414794575 |
| observedCumulativeLayoutShift | 0 Sec |
| observedLastVisualChangeTs | 1015419931065 |
| cumulativeLayoutShift | 0 Sec |
| totalCumulativeLayoutShift | 0 Sec |
| speedIndex | 3.59 Sec |
| largestContentfulPaint | 4.62 Sec |
| observedNavigationStart | 0 Sec |
| observedTimeOriginTs | 1015414511065 |
| firstContentfulPaint | 0.83 Sec |
| observedFirstVisualChangeTs | 1015414848065 |
| observedTraceEndTs | 1015422487730 |
| observedFirstVisualChange | 0.34 Sec |
| observedLargestContentfulPaintTs | 1015415866875 |
| observedFirstPaint | 0.3 Sec |
| observedFirstContentfulPaintAllFramesTs | 1015414813474 |
| observedLoadTs | 1015416544304 |
| observedLastVisualChange | 5.42 Sec |
| observedFirstMeaningfulPaint | 1.36 Sec |
| observedLargestContentfulPaintAllFramesTs | 1015415866875 |
